Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

More pediatric-specific research and guidelines are needed to improve hidradenitis suppurativa treatment in children and adolescents.

Anti-CD19 therapy may help treat SLE and NMOSD.

Mixed Connective Tissue Disease can develop from overlapping symptoms of several autoimmune diseases, making diagnosis complex.

Early recognition and management of gastrointestinal tuberculosis in lupus patients are crucial to prevent complications.

Trans-esophageal echocardiography is crucial for accurately diagnosing heart issues in lupus patients.

Correct diagnosis is crucial for treating overlapping conditions like NMOSD and SLE effectively.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

Biologics and small molecules can effectively treat inflammatory nail disorders, but personalized treatment plans are important.

Cyclosporine cleared a woman's resistant skin condition quickly and kept it away for over a year.

Secukinumab treatment may cause HBV reactivation and hair discoloration.

Current treatments for neutrophilic alopecias in children are limited and often ineffective, especially for males and those of Afro-Caribbean descent.

Experts recommend specific treatments for alopecia areata based on age and severity, emphasizing the need for better treatments and acknowledging its psychological impact.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

There is no standardized treatment for hidradenitis suppurativa, and individualized plans are needed.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

Topical corticosteroids are the main treatment for Erosive Pustular Dermatosis, but recurrence is common after stopping treatment.

Azathioprine is a safe and effective long-term treatment for severe alopecia areata, significantly improving hair regrowth.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Managing skin diseases during pregnancy and postpartum requires careful consideration of treatment safety and dosing to protect both mother and baby.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Botulinum Neurotoxin-A can treat acne, oily skin, rosacea, hair loss, prevent scars, relieve nerve pain, reduce excessive sweating, and manage psoriasis, but more trials are needed to confirm its effectiveness.

Secukinumab and acitretin together may quickly and effectively treat severe generalized pustular psoriasis.

The congress highlighted concerns about the effectiveness of over-the-counter nail treatments, the link between hair loss and daily care products, and the safety of skin treatments during COVID-19.

Retinoids might cause temporary hyperthyroidism in some patients.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.